0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sepsis Diagnostic Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-11D6280
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Sepsis Diagnostic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sepsis Diagnostic Market Insights, Forecast to 2029

Code: QYRE-Auto-11D6280
Report
August 2023
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sepsis Diagnostic Market Size

The global Sepsis Diagnostic market is projected to grow from US$ 371.7 million in 2023 to US$ 502.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Sepsis Diagnostic Market

Sepsis Diagnostic Market

Market Analysis and Insights: Global Sepsis Diagnostic Market
The US & Canada market for Sepsis Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Sepsis Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Sepsis Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Sepsis Diagnostic include Bruker (US), CytoSorbents (US), EKF (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), bioMerieux (France), Danaher (US) and Becton, Dickinson and Company (US), etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Sepsis Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Sepsis Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sepsis Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sepsis Diagnostic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Sepsis Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Sepsis Diagnostic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bruker (US), CytoSorbents (US), EKF (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), bioMerieux (France), Danaher (US) and Becton, Dickinson and Company (US), etc.

Scope of Sepsis Diagnostic Market Report

Report Metric Details
Report Name Sepsis Diagnostic Market
Accounted market size in 2023 US$ 371.7 million
Forecasted market size in 2029 US$ 502.7 million
CAGR 5.2
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Laboratory Tests
  • Point-of-care Tests
Segment by Application
  • Hospitals
  • Pathology & Reference Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bruker (US), CytoSorbents (US), EKF (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), bioMerieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), Abbott (US)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Sepsis Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sepsis Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis Diagnostic revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Sepsis Diagnostic Market growing?

Ans: The Sepsis Diagnostic Market witnessing a CAGR of 5.2 during the forecast period 2023-2029.

What is the Sepsis Diagnostic Market size in 2029?

Ans: The global Sepsis Diagnostic market is projected to grow from US$ 371.7 million in 2023 to US$ 502.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2018-2029)
2.2 Global Sepsis Diagnostic Growth Trends by Region
2.2.1 Sepsis Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sepsis Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Sepsis Diagnostic Market Dynamics
2.3.1 Sepsis Diagnostic Industry Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sepsis Diagnostic by Players
3.1.1 Global Sepsis Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sepsis Diagnostic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2022
3.5 Global Key Players of Sepsis Diagnostic Head office and Area Served
3.6 Global Key Players of Sepsis Diagnostic, Product and Application
3.7 Global Key Players of Sepsis Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2024-2029)
5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sepsis Diagnostic Market Size (2018-2029)
6.2 North America Sepsis Diagnostic Market Size by Type
6.2.1 North America Sepsis Diagnostic Market Size by Type (2018-2023)
6.2.2 North America Sepsis Diagnostic Market Size by Type (2024-2029)
6.2.3 North America Sepsis Diagnostic Market Share by Type (2018-2029)
6.3 North America Sepsis Diagnostic Market Size by Application
6.3.1 North America Sepsis Diagnostic Market Size by Application (2018-2023)
6.3.2 North America Sepsis Diagnostic Market Size by Application (2024-2029)
6.3.3 North America Sepsis Diagnostic Market Share by Application (2018-2029)
6.4 North America Sepsis Diagnostic Market Size by Country
6.4.1 North America Sepsis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Sepsis Diagnostic Market Size by Country (2018-2023)
6.4.3 North America Sepsis Diagnostic Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2018-2029)
7.2 Europe Sepsis Diagnostic Market Size by Type
7.2.1 Europe Sepsis Diagnostic Market Size by Type (2018-2023)
7.2.2 Europe Sepsis Diagnostic Market Size by Type (2024-2029)
7.2.3 Europe Sepsis Diagnostic Market Share by Type (2018-2029)
7.3 Europe Sepsis Diagnostic Market Size by Application
7.3.1 Europe Sepsis Diagnostic Market Size by Application (2018-2023)
7.3.2 Europe Sepsis Diagnostic Market Size by Application (2024-2029)
7.3.3 Europe Sepsis Diagnostic Market Share by Application (2018-2029)
7.4 Europe Sepsis Diagnostic Market Size by Country
7.4.1 Europe Sepsis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Sepsis Diagnostic Market Size by Country (2018-2023)
7.4.3 Europe Sepsis Diagnostic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sepsis Diagnostic Market Size (2018-2029)
8.2 China Sepsis Diagnostic Market Size by Type
8.2.1 China Sepsis Diagnostic Market Size by Type (2018-2023)
8.2.2 China Sepsis Diagnostic Market Size by Type (2024-2029)
8.2.3 China Sepsis Diagnostic Market Share by Type (2018-2029)
8.3 China Sepsis Diagnostic Market Size by Application
8.3.1 China Sepsis Diagnostic Market Size by Application (2018-2023)
8.3.2 China Sepsis Diagnostic Market Size by Application (2024-2029)
8.3.3 China Sepsis Diagnostic Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sepsis Diagnostic Market Size (2018-2029)
9.2 Asia Sepsis Diagnostic Market Size by Type
9.2.1 Asia Sepsis Diagnostic Market Size by Type (2018-2023)
9.2.2 Asia Sepsis Diagnostic Market Size by Type (2024-2029)
9.2.3 Asia Sepsis Diagnostic Market Share by Type (2018-2029)
9.3 Asia Sepsis Diagnostic Market Size by Application
9.3.1 Asia Sepsis Diagnostic Market Size by Application (2018-2023)
9.3.2 Asia Sepsis Diagnostic Market Size by Application (2024-2029)
9.3.3 Asia Sepsis Diagnostic Market Share by Application (2018-2029)
9.4 Asia Sepsis Diagnostic Market Size by Region
9.4.1 Asia Sepsis Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Sepsis Diagnostic Market Size by Region (2018-2023)
9.4.3 Asia Sepsis Diagnostic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Sepsis Diagnostic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Sepsis Diagnostic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Details
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.1.5 Bruker (US) Recent Developments
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Details
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.2.5 CytoSorbents (US) Recent Developments
11.3 EKF (US)
11.3.1 EKF (US) Company Details
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.3.5 EKF (US) Recent Developments
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Details
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.4.5 T2 Biosystems (US) Recent Developments
11.5 Luminex (US)
11.5.1 Luminex (US) Company Details
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.5.5 Luminex (US) Recent Developments
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Details
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.6.5 Thermo Fisher Scientific (US) Recent Developments
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Details
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2018-2023)
11.7.5 bioMerieux (France) Recent Developments
11.8 Danaher (US)
11.8.1 Danaher (US) Company Details
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.8.5 Danaher (US) Recent Developments
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Details
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.9.5 Becton, Dickinson and Company (US) Recent Developments
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Details
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2018-2023)
11.10.5 Roche (Switzerland) Recent Developments
11.11 Abbott (US)
11.11.1 Abbott (US) Company Details
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2018-2023)
11.11.5 Abbott (US) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Laboratory Tests
    Table 3. Key Players of Point-of-care Tests
    Table 4. Global Sepsis Diagnostic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 5. Global Sepsis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Sepsis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Sepsis Diagnostic Market Share by Region (2018-2023)
    Table 8. Global Sepsis Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Sepsis Diagnostic Market Share by Region (2024-2029)
    Table 10. Sepsis Diagnostic Market Trends
    Table 11. Sepsis Diagnostic Market Drivers
    Table 12. Sepsis Diagnostic Market Challenges
    Table 13. Sepsis Diagnostic Market Restraints
    Table 14. Global Sepsis Diagnostic Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Sepsis Diagnostic Revenue Share by Players (2018-2023)
    Table 16. Global Top Sepsis Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2022)
    Table 17. Global Sepsis Diagnostic Industry Ranking 2021 VS 2022 VS 2023
    Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Global Key Players of Sepsis Diagnostic, Headquarters and Area Served
    Table 20. Global Key Players of Sepsis Diagnostic, Product and Application
    Table 21. Global Key Players of Sepsis Diagnostic, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2018-2023)
    Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2024-2029)
    Table 27. Global Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Sepsis Diagnostic Revenue Share by Application (2018-2023)
    Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Sepsis Diagnostic Revenue Share by Application (2024-2029)
    Table 31. North America Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 32. North America Sepsis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
    Table 33. North America Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 34. North America Sepsis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
    Table 35. North America Sepsis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Sepsis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Sepsis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 39. Europe Sepsis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
    Table 40. Europe Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 41. Europe Sepsis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
    Table 42. Europe Sepsis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Europe Sepsis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Europe Sepsis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
    Table 45. China Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 46. China Sepsis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
    Table 47. China Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 48. China Sepsis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
    Table 49. Asia Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Asia Sepsis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Asia Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Asia Sepsis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Asia Sepsis Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 54. Asia Sepsis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
    Table 55. Asia Sepsis Diagnostic Market Size by Region (2024-2029) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Sepsis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 61. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
    Table 63. Bruker (US) Company Details
    Table 64. Bruker (US) Business Overview
    Table 65. Bruker (US) Sepsis Diagnostic Product
    Table 66. Bruker (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 67. Bruker (US) Recent Developments
    Table 68. CytoSorbents (US) Company Details
    Table 69. CytoSorbents (US) Business Overview
    Table 70. CytoSorbents (US) Sepsis Diagnostic Product
    Table 71. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 72. CytoSorbents (US) Recent Developments
    Table 73. EKF (US) Company Details
    Table 74. EKF (US) Business Overview
    Table 75. EKF (US) Sepsis Diagnostic Product
    Table 76. EKF (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 77. EKF (US) Recent Developments
    Table 78. T2 Biosystems (US) Company Details
    Table 79. T2 Biosystems (US) Business Overview
    Table 80. T2 Biosystems (US) Sepsis Diagnostic Product
    Table 81. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 82. T2 Biosystems (US) Recent Developments
    Table 83. Luminex (US) Company Details
    Table 84. Luminex (US) Business Overview
    Table 85. Luminex (US) Sepsis Diagnostic Product
    Table 86. Luminex (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 87. Luminex (US) Recent Developments
    Table 88. Thermo Fisher Scientific (US) Company Details
    Table 89. Thermo Fisher Scientific (US) Business Overview
    Table 90. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
    Table 91. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 92. Thermo Fisher Scientific (US) Recent Developments
    Table 93. bioMerieux (France) Company Details
    Table 94. bioMerieux (France) Business Overview
    Table 95. bioMerieux (France) Sepsis Diagnostic Product
    Table 96. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 97. bioMerieux (France) Recent Developments
    Table 98. Danaher (US) Company Details
    Table 99. Danaher (US) Business Overview
    Table 100. Danaher (US) Sepsis Diagnostic Product
    Table 101. Danaher (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 102. Danaher (US) Recent Developments
    Table 103. Becton, Dickinson and Company (US) Company Details
    Table 104. Becton, Dickinson and Company (US) Business Overview
    Table 105. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
    Table 106. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 107. Becton, Dickinson and Company (US) Recent Developments
    Table 108. Roche (Switzerland) Company Details
    Table 109. Roche (Switzerland) Business Overview
    Table 110. Roche (Switzerland) Sepsis Diagnostic Product
    Table 111. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 112. Roche (Switzerland) Recent Developments
    Table 113. Abbott (US) Company Details
    Table 114. Abbott (US) Business Overview
    Table 115. Abbott (US) Sepsis Diagnostic Product
    Table 116. Abbott (US) Revenue in Sepsis Diagnostic Business (2018-2023) & (US$ Million)
    Table 117. Abbott (US) Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sepsis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Sepsis Diagnostic Market Share by Type: 2022 VS 2029
    Figure 3. Laboratory Tests Features
    Figure 4. Point-of-care Tests Features
    Figure 5. Global Sepsis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 6. Global Sepsis Diagnostic Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Pathology & Reference Laboratories Case Studies
    Figure 9. Sepsis Diagnostic Report Years Considered
    Figure 10. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global Sepsis Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Sepsis Diagnostic Market Share by Region: 2022 VS 2029
    Figure 13. Global Sepsis Diagnostic Market Share by Players in 2022
    Figure 14. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2022
    Figure 16. North America Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America Sepsis Diagnostic Market Share by Type (2018-2029)
    Figure 18. North America Sepsis Diagnostic Market Share by Application (2018-2029)
    Figure 19. North America Sepsis Diagnostic Market Share by Country (2018-2029)
    Figure 20. United States Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Sepsis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
    Figure 23. Europe Sepsis Diagnostic Market Share by Type (2018-2029)
    Figure 24. Europe Sepsis Diagnostic Market Share by Application (2018-2029)
    Figure 25. Europe Sepsis Diagnostic Market Share by Country (2018-2029)
    Figure 26. Germany Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. China Sepsis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
    Figure 33. China Sepsis Diagnostic Market Share by Type (2018-2029)
    Figure 34. China Sepsis Diagnostic Market Share by Application (2018-2029)
    Figure 35. Asia Sepsis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. Asia Sepsis Diagnostic Market Share by Type (2018-2029)
    Figure 37. Asia Sepsis Diagnostic Market Share by Application (2018-2029)
    Figure 38. Asia Sepsis Diagnostic Market Share by Region (2018-2029)
    Figure 39. Japan Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. South Korea Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. China Taiwan Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. India Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Australia Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Sepsis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Sepsis Diagnostic Market Share by Type (2018-2029)
    Figure 47. Middle East, Africa, and Latin America Sepsis Diagnostic Market Share by Application (2018-2029)
    Figure 48. Middle East, Africa, and Latin America Sepsis Diagnostic Market Share by Country (2018-2029)
    Figure 49. Brazil Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Mexico Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Turkey Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Israel Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. GCC Countries Sepsis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 56. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 57. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 58. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 59. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 60. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 61. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 62. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 63. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 64. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 65. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2018-2023)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS